Tag:
off-label promotion
Latest Headlines
Latest Headlines
Medtronic will pay $85M to resolve Infuse shareholder suit
Medtronic ($MDT) must fork over $85 million to put a massive shareholder class action lawsuit behind it over the company's Infuse bone graft material.
Medtronic faces more shareholder ire over Infuse
Medtronic ( $MDT ) is facing additional fallout over Infuse bone growth protein, which has been tied to an increased risk of male infertility.
Medtronic named in qui tam stent case
Last month, it appeared as if Medtronic had avoided being sued for promoting biliary stents for off-label purposes. But now the Minnesota-based company now joins the likes of Boston Scientific,
